Literature DB >> 26648983

Factor analysis of the biochemical markers related to liver cirrhosis.

Hyun-Jin Kim1, Hae-Kag Lee2, Jae-Hwan Cho3.   

Abstract

OBJECTIVES: The purpose of this study was to find the correlations between biochemical study and liver cirrhosis.
METHODS: The patients had liver biopsy to check the degree of their liver fibrosis, from August 2013 to August 2014 at the current medical center. In order to find the etiology of hepatitis, a research was done on gender, age, weight, and biochemical study through the investigation of subjects' medical record and medical history. For biochemical study, we examined hemoglobin, platelets, albumin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin, gamma-glutamyl transferase (GGT), prothrombin time (PT), and international normalised ratio (INR). We also analyzed the factors that are related to liver cirrhosis.
RESULTS: As a result, the patients at liver cirrhosis F≥2 stage showed 0.973, which is higher than the patients at FO stage with 0.943. F≥2 stage of hemoglobin was 0.544, which is lower than FO stage of hemoglobin with 0.817. Platelet count in F≥2 stage was 0.417, which is higher than FO stage with 0.074. For Albumin, F≥2 stage was 0.155 when F0 stage was 0.135. ATS's F≥2 stage was 0.665, which is 6 times higher than FO stage with 0.100. Moreover, in the case of GGT, F≥2 stage was higher with 0.492 than FO stage with 0.078.
CONCLUSIONS: In conclusion, it was confirmed that there is an increase in liver cirrhosis in the following general characteristics and biochemical factors: increase of age, increase of GGT, decrease of albumin, increase of the total bilirubin, and growth of INR (International Normalized Ratio).

Entities:  

Keywords:  Biochemical study; Correlations; Liver cirrhosis

Year:  2015        PMID: 26648983      PMCID: PMC4641252          DOI: 10.12669/pjms.315.8025

Source DB:  PubMed          Journal:  Pak J Med Sci        ISSN: 1681-715X            Impact factor:   1.088


INTRODUCTION

Liver cirrhosis is a disease when a normal cell is replaced with scar tissue, and the human body becomes disturbed in the performance of essential functions. In liver cirrhosis, liver cells are destroyed without being regenerated, and they become solid and are decreased.1-4 Liver cirrhosis is a liver disease and one of the liver cancers. It is also one of the main chronic diseases or the main cause of liver disease in Korea. Compared to the Westerners, Koreans are more likely to get infected by hepatitis, there is a higher repetition rate of liver cirrhosis.5,6 Since the rate of drinking alcoholic beverages is increasing7, the occurrence of chronic liver disease is becoming worse. Liver cirrhosis mostly appears when chronic hepatitis due to hepatitis virus is not well treated. Because of the hepatitis and other factors, normal liver cells are destroyed and they decrease in numbers; this changes the normal structure of liver and disturbs the liver functions.8,9 There are no specific symptoms of liver cirrhosis at early stages. However, as more liver cells are destroyed, the production of proteins that manage body fluid congestion and blood coagulation, and the metabolism of bilirubin are decreased. For these reasons, there are various complications. Deaths frequently occur due to the serious damage in the liver due to various complications. Therefore, it is very important to prevent varicose vein, seroperitoneum and edema, hepatic encephalopathy, and liver cancer to treat liver cirrhosis.10 The methods used for examination and diagnosis of liver cirrhosis are imaging diagnosis and tissue pathology diagnosis; and computed tomography (CT), magnetic resonance imaging (MRI), and Sonography are being widely used. CT and MRI are costly, and they have side-effects due to the use of contrast media. On the other hand, Sonography is preferred for imaging diagnosis of liver cirrhosis because of its safety, repeatability, and cost.11 In terms of variables related to the symptoms of liver cirrhosis, sociological variables such as age and gender have been reported.12 In most of the studies, only the correlation of child-pugh score (sometimes the Child-Turcotte-Pugh score), etiology of liver cirrhosis, and physiological variables have been confirmed.13,14 However, there has been no clear report about factors related to blood count and biochemical test. Therefore, this study was conducted to find the correlation between biochemical test and liver cirrhosis.

METHODS

A retrospective analysis was conducted on 304 patients who underwent ultrasound test before and after the liver biopsy. They were selected among the patients who received liver biopsy to check the degree of liver fibrosis, from August 2013 to August 2014 at the current hospital. In order to find the etiology of hepatitis, a research was conducted on gender, age, weight, and biochemical study by investigating the subjects’ medical record and medical history. In serological study, the patients with chronic hepatitis B virus had positive HBsAg for over-6-month, and the patients with chronic hepatitis C virus had positive anti-HCV and hepatitis C virus (HCV) RNA for over-6-month. The patients with alcoholic hepatitis were also included in this study. Other types of hepatitis caused by the unidentified factors were excluded. There were a total of 221 subjects which included 144 patients with hepatitis B virus (HBV), 71 patients with HCV, and 6 patients with alcoholic hepatitis. Among all of the subjects, there were 125 men (56.6%) and 96 women (44.3%), and the average age of the subjects was 54.79±11.46. The ultrasound guided percutaneous liver biopsy was performed with a fixed sample with formalin solution. The sample was fixed with formalin solution and treated with paraffin. Then, masson-trichrome staining was done to have a precise understanding of the liver fibrosis and the staining with hematoxylin-eosin was done after sectioning into a thickness of 5μm. According to the guidelines of Korean Society of Pathologies’ digestive system of pathology, the system and labeling of hepatitis are categorized into the followings: no fibrosis (F0), portal fibrosis (F1), periportal fibrosis without liver cirrhosis (F2), septal fibrosis (F3), and liver cirrhosis (cirrhosis, F4).15 In addition, F≥2 stage was analyzed by dividing into significant fibrosis, and F≥3 stage by dividing into advanced fibrosis. The following 5 items were used for evaluating the individual index: gender, age, height, weight, and degree of obesity. In order to process biochemical index, subjects were instructed to fast for at least 12 hours, and blood and urine tests were given. With the outcomes, we examined 9 factors including the followings: hemoglobin, platelets, albumin, AST, ALT, total bilirubin, GGT, PT, and INR. In order to analyze the factors related to liver cirrhosis, we performed Pearson Correlation coefficient and linear regression analysis. In addition, we conducted logistic regression analysis on the related factors, Pearson’s Chi-square test by subject’s general characteristic, and Pearson’s Chi-square test by hematological index.

RESULTS

The results from the frequency analysis of liver cirrhosis by subjects were as follows: 19 patients in F=0 stage (8.6%), which indicates normal; 29 patients in F≥1 stage (13.1%); 50 patients in F≥2 stage (22.6%); 51 patients in F≥3 stage (23.1%); and 72 patients in F≥4 stage (32.6%) (Table-I). In order to identify the characteristic correlation between liver cirrhosis and variables, we conducted simple correlation analysis by variables. As a result, we found the correlation in variables as follows: age was positive 0.260, Hemoglobin (g/dL) was negative 0.152, Platelet (10³/UL) was negative 0.287, AST (IU/L) was positive 0.209, Total bilirubin (mg/dL) was positive 0.194, GGT (IU/L) was positive 0.175, prothrombin time(%) was negative 0.178, and INR was positive 0.352 (p<0.05) (Table-II). By conducting linear regression analysis on liver cirrhosis related factors, we were able to compute constant, standard error, and significant probability of each variable and liver biopsy result. There was statistical significance between the result from liver biopsy of liver cirrhosis and the value of age, platelet (10³/UL), INR in 0.000, Hemoglobin (g/dL) in 0.024, Total bilirubin (mg/dL) in 0.004, and prothrombin time(%) in 0.008 (p<0.05) (Table-III). For the precise correlation analysis, simple correlation analysis was performed, and then the multivariate analysis was conducted through logistic regression analysis by using related variables to obtain the odds ratio [Exp(B)]. The odds ratio [Exp(B)] in age for liver cirrhosis patients in F≥2 stage was 0.973 which is higher than the patients in FO stage that was 0.943. For Hemoglobin, F≥2 stage was 0.544 which is lower than F0 that was 0.817. For Platelet count, F≥2 stage was 0.417 which is higher than FO stage that was 0.074. Also, Albumin’s F≥2 stage was 0.155 which is higher than F0 stage that was 0.135. AST’s F≥2 stage was 0.665 which is over 6 times higher than FO stage that was 0.100. Gamma GT’s F≥2 stage was 0.492 which is higher than FO stage that was 0.078 (Table-IV).
Table-I

The results from the frequency analysis of liver cirrhosis.

DivisionLiver cirrhosisFrequency%
BiopsyF=0198.6
F≥12913.1
F≥25022.6
F≥35123.1
F=47232.6
Table-II

The characteristic correlation between liver cirrhosis and variables.

VariableLiver cirrhosisVariableLiver cirrhosis
Sex-0.0751AST0.209
Years0.2602ALT0.073
Height-0.004Total bilirubin0.194
Weight0.0003GGT0.175
Obesity0.0154PT-0.178
Pathogenesis0.0805INR0.352
Hemoglobin-0.152
Platelets-0.287
Albumin-0.230

Aspartate aminotransferase,

Alanine aminotransferase,

Gamma-glutamyl transferase,

Prothrombin time,

International normalised ratio

Table-III

Linear regression analysis on liver cirrhosis related factors.

VariableBSE
Age2.2990.577
Hemoglobin-0.2300.101
Platelets-19.2714.348
Albumin-0.1730.039
1AST6.5402.073
total bilirubin0.4140.141
2GGT10.4233.963
3PT-5.2631.967
4INR0.0630.011

Aspartate aminotransferase,

Gamma-glutamyl transferase,

Prothrombin time,

International normalised ratio

Table-IV

Logistic regression analysis on liver cirrhosis related factors.

VariableBiopsy ClassificationBSEExp(B)
Age0-0.0590.0230.943
1-0.0690.0200.933
2-0.0270.0160.973
3-0.0230.0160.977
Hemoglobin0-0.2030.5320.817
1-1.4960.5890.224
2-0.6080.3950.544
3-1.0750.4260.341
Platelets0-2.6060.6780.074
1-1.5820.4640.206
2-0.8760.3760.417
3-0.1320.3820.876
Albumin0-2.0031.0600.135
1-2.4451.0500.087
2-1.8640.6490.155
3-1.3320.5380.264
AST0-2.3070.7840.100
1-0.9660.4660.381
2-0.4080.3700.665
3-0.3640.3680.695
Total bilirubin0-2.8571.0660.467
1-0.8070.6010.446
2-1.1710.5420.310
3-0.3850.4430.680
GGT0-2.5541.0550.078
1-0.6290.4790.533
2-0.7090.4010.492
3-1.2040.4380.300
PT0-0.6930.5730.500
1-0.4620.4670.630
2-0.1530.3770.858
3-0.1020.3730.903

1Aspartate aminotransferase, 2Gamma-glutamyl transferase, 3Prothrombin time, 4International normalised ratio

The results from the frequency analysis of liver cirrhosis. The characteristic correlation between liver cirrhosis and variables. Aspartate aminotransferase, Alanine aminotransferase, Gamma-glutamyl transferase, Prothrombin time, International normalised ratio Linear regression analysis on liver cirrhosis related factors. Aspartate aminotransferase, Gamma-glutamyl transferase, Prothrombin time, International normalised ratio Logistic regression analysis on liver cirrhosis related factors. 1Aspartate aminotransferase, 2Gamma-glutamyl transferase, 3Prothrombin time, 4International normalised ratio

DISCUSSION

In this study, we analyzed the correlations between liver cirrhosis and general characteristic, as well as liver cirrhosis and biochemical examination of blood. Some factors showed a negative correlation. Coco and others have reported that the counts of ALT and AST were elevated in the patients with chronic viral hepatitis.16,17 According to other studies, the changes of total bilirubin count had an impact on liver cirrhosis.18 In our study, we looked for other factors that affect liver stiffness from these patients with chronic liver disease. As a result of analyzing how individual characteristic index and biochemical index of blood are related to liver cirrhosis, the followings were shown: growth of elderly, increase of GGT, decrease of albumin, increase of total bilirubin, and decrease of Gamma GT. Although there was an increase of total bilirubin in other studies, there was no report on the changes of ALT value, which differentiate this study from other studies. A decrease of albumin can cause tissue edema, which results in more serious liver disease and liver cirrhosis. On the basis of the result of this study, overall clinical factors should be considered through medical history, serological examination, and imaging examination of the patients with chronic liver disease, who have no signs of acute exacerbation or superinfection of other acute hepatitis. Especially, when there are growth of elderly, increase of GGT, decrease of albumin and increase of total bilirubin, we can measure liver cirrhosis because these are the signs of increased liver cirrhosis. If there were growth of elderly, increase of gamma GT, decrease of albumin, increase of total bilirubin and increase of INR, it indicates that the liver cirrhosis is being enhanced. Through this study, we assumed that there has to be a massive retrospective study about the direct cause of liver cirrhosis, since it has not been discovered yet.

CONCLUSIONS

In conclusion, it was confirmed that there is an increase in liver cirrhosis in the following general characteristics and biochemical factors: increase of age, increase of GGT, decrease of albumin, increase of the total bilirubin, and growth of INR (International Normalized Ratio).
  14 in total

1.  Fatigue in patients with chronic hepatitis C.

Authors:  T Poynard; P Cacoub; V Ratziu; R P Myers; M H Dezailles; A Mercadier; P Ghillani; F Charlotte; J C Piette; J Moussalli
Journal:  J Viral Hepat       Date:  2002-07       Impact factor: 3.728

Review 2.  Gene therapeutic approaches to inhibit hepatitis B virus replication.

Authors:  Maren Gebbing; Thorsten Bergmann; Eric Schulz; Anja Ehrhardt
Journal:  World J Hepatol       Date:  2015-02-27

3.  Neighborhood-pixels algorithm combined with Sono-CT in the diagnosis of cirrhosis: an experimental study.

Authors:  Rui Li; Xing Hua; Yanli Guo; Ping Zhang; Aiming Guo
Journal:  Ultrasound Med Biol       Date:  2006-10       Impact factor: 2.998

4.  Factors associated with poor health-related quality of life of patients with cirrhosis.

Authors:  G Marchesini; G Bianchi; P Amodio; F Salerno; M Merli; C Panella; C Loguercio; G Apolone; M Niero; R Abbiati
Journal:  Gastroenterology       Date:  2001-01       Impact factor: 22.682

5.  Interleukin-10 gene promoter polymorphism and risk of liver cirrhosis.

Authors:  Y Liu; M C Yu; A Q Zhang; Y B Wang; K Jiang; J H Dong
Journal:  Genet Mol Res       Date:  2015-02-13

Review 6.  Muscle cramps: a 'complication' of cirrhosis.

Authors:  P J Marotta; I W Graziadei; C N Ghent
Journal:  Can J Gastroenterol       Date:  2000-11       Impact factor: 3.522

7.  [Risk factor analysis of postoperative complications in gastric carcinoma patients complicated with liver cirrhosis].

Authors:  Yufei Zhang; Feng Wang; Guangquan Zong; Lin Xu; Ji Xuan
Journal:  Zhonghua Wei Chang Wai Ke Za Zhi       Date:  2015-01

8.  Use of administrative claims data for identifying patients with cirrhosis.

Authors:  Mahendra S Nehra; Ying Ma; Christopher Clark; Ruben Amarasingham; Don C Rockey; Amit G Singal
Journal:  J Clin Gastroenterol       Date:  2013 May-Jun       Impact factor: 3.062

9.  [Bilirubin metabolism in liver cirrhosis].

Authors:  A Ohkubo
Journal:  Nihon Rinsho       Date:  1994-01

10.  [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].

Authors:  Sun Min Kim; Joo Hyun Sohn; Tae Yeob Kim; Young Wook Roh; Chang Soo Eun; Yong Cheol Jeon; Dong Soo Han; Young Ha Oh
Journal:  Korean J Hepatol       Date:  2009-12
View more
  2 in total

1.  Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients.

Authors:  Rong-Qi Wang; Qing-Shan Zhang; Su-Xian Zhao; Xue-Min Niu; Jing-Hua Du; Hui-Juan Du; Yue-Min Nan
Journal:  J Int Med Res       Date:  2016-11-11       Impact factor: 1.671

2.  INR-to-platelet ratio (INPR) as a novel noninvasive index for predicting liver fibrosis in chronic hepatitis B.

Authors:  Rongrong Ding; Jianming Zheng; Dan Huang; Yanbing Wang; Xiufen Li; Xinlan Zhou; Li Yan; Wei Lu; Zongguo Yang; Zhanqing Zhang
Journal:  Int J Med Sci       Date:  2021-01-09       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.